Technology ID
TAB-5096

48-Position Custom Deep Well Plate For In Vitro Equilibrium Dialysis at a 1:1 Sample to Buffer Volume Ratio

E-Numbers
E-101-2023-0
Lead Inventor
Ribera, Ashley
Lead IC
CDC
Co-Inventors
Zhou, Hui
Vesper, Hubert
ICs
CDC
Applications
Research Materials
Diagnostics
Therapeutic Areas
Urology
Reproductive Health
Obstetrics/Neo-Natal
Hematology
Geriatrics
Endocrinology
Development Stages
Analytical Assay Performance Stage
Development Status
Clinical Assay Development Stage

CDC scientists have developed a new design for a multi-well dialysis microplate for equilibrium dialysis. The unique design accommodates a 1:1 buffer to sample ratio and provides additional room at the base of the well to enable optimal cartridge immersion and analyte diffusion. The microplate is readily adaptable into existing automated analytical systems and meets the criteria of American National Standards Institute (ANSI). The microplate is designed for measuring blood or other biological fluid samples over a wide range of sample volumes and may be used in a high throughput manner. Use of the microplate has been shown to reduce errors, while increasing accuracy, precision, and sensitivity.

 Thus far, the microplate has been successfully used for free testosterone measurement. The microplate may also be used for measuring other analytes and has the potential to be used in both clinical and research settings.  

Commercial Applications
  • Diagnostics: Meets the criteria of American National Standards Institute (ANSI).
  • Research Materials.
Competitive Advantages
  • Diagnostics: Dialysis microplate for measuring free hormone analytes such as free testosterone, free thyroxine (FT4), triiodothyronine, as well as measuring unbound drugs such as dolutegravir in diagnostic or research settings.
  • Public Health: Use of the dialysis microplate to provide dialysis testing services for customers.
Licensing Contact:
Taylor-Mulneix, Dawn
dawn.taylor-mulneix@nih.gov